Urteste S.A.
WSE: URT.WA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Warsaw Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Grzegorz Stefanski
- Employees
- 31
- Headquarters
- Gdansk, Poland
- IPO year
- 2021
- Market cap
- PLN 66.4M
- Website
- https://www.urteste.com
Loading URT…
Loading profile data…Frequently asked questions about URT
What does Urteste S.A. (URT.WA) do?
Urteste S.A. engages in the research and development of diagnostic tests for cancers. It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, stomach, lung, oesophagus, ovary, endometrium, blood, breast, and nervous system cancer. The company was incorporated in 2021 and is based in Gdansk, Poland.
Where does URT.WA trade?
Urteste S.A. (URT.WA) trades on the Warsaw Stock Exchange.
What sector is URT.WA in?
Urteste S.A. (URT.WA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Urteste S.A.?
Grzegorz Stefanski is the chief executive officer of Urteste S.A. (URT.WA).
Where is Urteste S.A. headquartered?
Urteste S.A. is headquartered in Poland.
Does URT.WA pay a dividend?
Urteste S.A. (URT.WA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did URT.WA go public?
Urteste S.A. (URT.WA) completed its initial public offering in 2021.